Slc25a1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients

HIGHLIGHTS

• who: SLC et al. from the Jiangsu University Affiliated People`s Hospital, China have published the research: SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients, in the Journal: (JOURNAL)
• what: To examine the predictive accuracy of the model, two more AML cohorts from the TCGA and TARGET databases (TARGET_AML) were used for validation using the same risk score algorithm followed by risk subgrouping, survival analysis and ROC curves. For the past few years, the research of SLC25A1 focused on its functions and mechanisms in solid tumors progression (Im et_al, 2014; Fernandez . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.